255 related articles for article (PubMed ID: 1347936)
1. Pharmacologic treatment of attention deficit hyperactivity disorder.
Greenhill LL
Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
[TBL] [Abstract][Full Text] [Related]
2. Clonidine for treatment of attention-deficit/hyperactivity disorder.
Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
[No Abstract] [Full Text] [Related]
3. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
[No Abstract] [Full Text] [Related]
4. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
[No Abstract] [Full Text] [Related]
5. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
Varley CK
Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
[No Abstract] [Full Text] [Related]
6. Dexmethylphenidate for attention deficit hyperactivity disorder.
Coury D
Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
[TBL] [Abstract][Full Text] [Related]
7. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
8. The stimulants.
Wilens TE; Biederman J
Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
[TBL] [Abstract][Full Text] [Related]
9. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
10. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
Ghanizadeh A
J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
[No Abstract] [Full Text] [Related]
11. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
12. An ADHD 6-year-old child ultrarapid metabolizer for CYP2D6.
Bonnet-Brilhault F; Broly F; Blanc R; Furet Y; Barthélémy C; Paintaud G
J Clin Psychopharmacol; 2006 Aug; 26(4):442-4. PubMed ID: 16855474
[No Abstract] [Full Text] [Related]
13. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
Higgins ES
J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
[TBL] [Abstract][Full Text] [Related]
14. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
Shalev R; Gross-Tsur V
Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
[No Abstract] [Full Text] [Related]
15. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
[TBL] [Abstract][Full Text] [Related]
16. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
17. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
18. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
Fone KC; Nutt DJ
Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
[TBL] [Abstract][Full Text] [Related]
19. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation of the effects of pharmacological treatment of children with attention deficit hyperactivity disorder].
Roselló B; Amado L; Presentación MJ
Rev Neurol; 1999 Feb; 28 Suppl 2():S177-82. PubMed ID: 10778510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]